跳至主要内容
临床试验/NCT03168425
NCT03168425已完成不适用

A Randomized Controlled Trial to Improve Discharge Opioid Prescribing After Cesarean Delivery

Vanderbilt University Medical Center2 个研究点 分布在 1 个国家目标入组 190 人开始时间: 2017年6月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
190
试验地点
2
主要终点
Unused Opioids

研究概览

简要总结

The number of opioid overdose deaths in the United States has quadrupled in 15 years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a sharp increase in the amount of legal prescription opioids dispensed. The abundance of prescription opioids available is a primary pathway for opioid abuse and diversion. Adjusting post- cesarean delivery opioid prescribing practices to better match actual patient need has the potential to reduce unused opioids available for diversion, nonmedical use, and development of chronic dependence, as well as reduce wasted resources.

详细描述

Preliminary data from a quality improvement project performed in our department found that most women are prescribed opioids after discharge that were significantly in excess of the actual opioids used. However there is a subset of women (~25%) who use all opioids and complain that they were not prescribed enough. The only variable predictive of post- discharge opioid use was Inpatient opioid use. These data were used to develop a formula for estimating outpatient use based on inpatient use. Currently there are no guidelines for outpatient prescribing either at our institution or on a national level. On average, most patients at our institution received 30 tablets of 5mg oxycodone at discharge. In surveying providers, very few looked at inpatient use and most had a standard prescription that they gave everyone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women 18-50 years old
  • Women undergoing cesarean delivery at a single institution

排除标准

  • Major post-surgical complications: cesarean hysterectomy, bowl or bladder injury, reoperation, ICU admission, wound infection or separation
  • Chronic opioid use: Taking buprenorphine during pregnancy, taking an opioid for > 7 days during pregnancy.
  • Non English or Spanish speaking

研究组 & 干预措施

Tailored

Experimental

Participants will be prescribed an opioid based on a formula derived from inpatient opioid use

干预措施: Tailored prescription (Other)

Control

Other

Participants will be prescribed 30 tablets of oxycodone 5mg, which is the average prescription currently given to our population.

干预措施: Control (Other)

结局指标

主要结局

Unused Opioids

时间窗: 4 weeks postpartum

oxycodone 5mg tablet leftover from prescription at discharge

次要结局

  • Pain: Frequency That Participants Reported Uncontrolled Pain(4 weeks postpartum)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Osmundson

Assistant Professor

Vanderbilt University Medical Center

研究点 (2)

Loading locations...

相似试验